Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (51-60 of 487) with videos related to

Pageof 49
Sort By:
The Oncologist|October 25, 2018
The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its MatchVivek Subbiah, Razelle Kurzrock
Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
Personalizing Precision Oncology: From Light Microscope to Molecular MicroscopeVivek Subbiah, Kanishka Sircar
Discovery Medicine|June 30, 2012
Ewing's sarcoma: overcoming the therapeutic plateauVivek Subbiah, Razelle Kurzrock
Cancer|April 3, 2023
Rare disease research powered by empowered patients: solving the zebra puzzle through social mediaGilberto Morgan, Vivek Subbiah
Trends in Cancer|June 20, 2026
Beyond one gene, one target: Next-generation precision oncologyVivek Subbiah, Razelle Kurzrock
Oncotarget|January 12, 2022
Unravelling the underpinnings of hyperprogression and immunotherapy: back to the benchVivek Subbiah, Razelle Kurzrock
The Oncologist|May 28, 2017
Debunking the Delusion That Precision Oncology Is an IllusionVivek Subbiah, Razelle Kurzrock
Expert Review of Precision Medicine and Drug Development|December 31, 2019
Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?Roman Groisberg, Vivek Subbiah
Trends in Cancer|December 9, 2022
Impact of tissue-agnostic approvals for patients with gastrointestinal malignanciesDeepak Bhamidipati, Vivek Subbiah
Trends in Cancer|July 30, 2023
Tumor-agnostic drug development in dMMR/MSI-H solid tumorsDeepak Bhamidipati, Vivek Subbiah
Pageof 49

Showing results (51-60 of 487) with videos related to

Sort By:
Pageof 49
The Oncologist|October 25, 2018
The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its MatchVivek Subbiah, Razelle Kurzrock
Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
Personalizing Precision Oncology: From Light Microscope to Molecular MicroscopeVivek Subbiah, Kanishka Sircar
Discovery Medicine|June 30, 2012
Ewing's sarcoma: overcoming the therapeutic plateauVivek Subbiah, Razelle Kurzrock
Cancer|April 3, 2023
Rare disease research powered by empowered patients: solving the zebra puzzle through social mediaGilberto Morgan, Vivek Subbiah
Trends in Cancer|June 20, 2026
Beyond one gene, one target: Next-generation precision oncologyVivek Subbiah, Razelle Kurzrock
Oncotarget|January 12, 2022
Unravelling the underpinnings of hyperprogression and immunotherapy: back to the benchVivek Subbiah, Razelle Kurzrock
The Oncologist|May 28, 2017
Debunking the Delusion That Precision Oncology Is an IllusionVivek Subbiah, Razelle Kurzrock
Expert Review of Precision Medicine and Drug Development|December 31, 2019
Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?Roman Groisberg, Vivek Subbiah
Trends in Cancer|December 9, 2022
Impact of tissue-agnostic approvals for patients with gastrointestinal malignanciesDeepak Bhamidipati, Vivek Subbiah
Trends in Cancer|July 30, 2023
Tumor-agnostic drug development in dMMR/MSI-H solid tumorsDeepak Bhamidipati, Vivek Subbiah
Pageof 49